Enclomiphene first month: what to expect week by week

Last updated 2026-07-30

What actually happens to your hormones in the first 4 weeks?

Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tricks your brain into thinking estrogen is low. The hypothalamus responds by pumping out more GnRH, which tells the pituitary to release more LH and FSH. More LH means more signal to the testes to make testosterone. That's the whole mechanism, and it's the opposite approach from injectable or gel TRT, which just adds testosterone from outside and shuts your own axis down. Because enclomiphene works upstream, the timeline looks different from TRT too. With injectable testosterone, levels can spike within days. With enclomiphene, you're waiting on a chain reaction: hypothalamus to pituitary to testes. Most compounding pharmacies and prescribers order the first follow-up labs at 4 to 6 weeks, and that's not arbitrary. It reflects roughly how long it takes LH to rise, testes to respond, and testosterone to reach a new steady state. In the clinical trials on enclomiphene citrate (the Androxal program, which never reached FDA approval despite completing Phase 3 work), researchers saw testosterone rise into the normal range within about 3 to 6 weeks in most hypogonadal men studied ^[1]. One published trial comparing enclomiphene to testosterone gel found that by week 6, a majority of men on enclomiphene reached total testosterone levels within the normal range while maintaining or increasing LH and FSH, whereas the gel group saw LH and FSH suppressed toward zero ^[2]. So by the end of week 4, expect your labs (if you get them) to show LH and total testosterone trending up. Free testosterone typically follows total T with a short lag. Estradiol may rise somewhat too, since more testosterone means more aromatization, though enclomiphene's antiestrogenic action at the hypothalamus doesn't block aromatase in peripheral tissue.

When do the symptoms actually start improving?

Symptom improvement almost always lags the labs. Expect the first two weeks to feel like not much is happening, then subtle shifts in weeks 3 and 4. Energy and morning wood are often the earliest reported changes, sometimes as early as week 2 to 3 for men who started with genuinely low testosterone. Libido tends to follow a bit later, often weeks 3 through 6, and it's less predictable, since libido depends on more than just total T (free T, estradiol balance, sleep, stress, baseline mental health all matter). Mood is the wild card. A meaningful minority of men report irritability or mood swings in the first few weeks, which some clinicians attribute to fluctuating estradiol as the whole axis recalibrates. This usually settles by week 4 to 6 as levels stabilize. If it doesn't settle, that's a signal to talk to your prescriber about dose (12.5 mg versus 25 mg) rather than push through. Don't expect visible changes like muscle gain or fat loss in month one. That's a 3+ month story, and even then it's modest compared to what supraphysiological TRT protocols can produce. If you're look for the fuller timeline past month one, the enclomiphene results timeline breaks down months two through six.

What side effects should you expect in the first month?

Most men tolerate enclomiphene reasonably well in month one, but it's not side-effect-free. The most commonly reported issues in trial data and clinical use include mood changes (irritability, some anxiety), headache, and occasional visual disturbances (blurring, floaters), the last of which is a known class effect of SERMs and a reason to stop and call your doctor if it happens ^[3]. In the enclomiphene versus testosterone gel trial mentioned above, adverse event rates were generally comparable between groups, and no unique safety signal specific to enclomiphene emerged over the study duration, though the trial arms were relatively small and short (about 3 months) ^[2]. That's worth being honest about: this is not a drug with a huge, long-term safety database in the way testosterone itself is, because it never finished the FDA approval process (more on that below). Less common but reported effects include hot flashes, breast tenderness, and, rarely, mood depression rather than elevation. If you have a history of blood clots or vision problems, tell your prescriber before starting, since SERMs as a class carry some association with visual and thromboembolic events, mostly documented with clomiphene and tamoxifen use. Week 1 to 2 is usually the roughest stretch for side effects if they're going to show up at all, since that's when hormone levels are actively shifting rather than settled. If nothing bothers you by week 3, it's unlikely to start.

Does enclomiphene preserve fertility in the first month, unlike TRT?

This is the reason most men look at enclomiphene instead of injections or gels in the first place, and the short answer is: yes, that's the expected mechanism, though month one is too early to prove it with your own labs. Exogenous testosterone (TRT) suppresses the hypothalamic-pituitary-gonadal axis. Your brain senses plenty of testosterone already circulating, so it stops sending LH and FSH signals to the testes. Without LH and FSH, sperm production drops, sometimes to zero, and testicles can shrink over months of use. This is well documented; a position paper from the American Urological Association and multiple fertility-focused reviews note that exogenous testosterone therapy is associated with impaired spermatogenesis and is generally not recommended for men who want to preserve fertility ^[4]. Enclomiphene does the opposite. Because it raises LH and FSH rather than replacing testosterone from outside, testicular signaling stays intact, or in many men improves, since the pituitary is now working harder. That's why testicular volume, which shrinks on TRT, is expected to remain stable or even increase slightly on enclomiphene, and why sperm parameters are expected to hold up in most men rather than collapse ^[1][2]. But here's the honest caveat: nobody has a large, dedicated trial tracking semen analysis specifically in month one of enclomiphene use. Sperm takes roughly 64 to 74 days to complete the full spermatogenic cycle, so even if enclomiphene supports the process from day one, you would not see the effect on an actual semen analysis until roughly 2 to 3 months in ^[5]. If fertility preservation during infertility treatment or family planning is your main goal, that's a conversation for a reproductive urologist, not something to assume from a first-month blood panel. For a broader look at what the evidence actually shows across studies, the enclomiphene reviews page rounds up the published research.

Is enclomiphene the same thing as clomiphene? (This affects what you're actually taking)

No, and the distinction matters for understanding what you're buying. Clomiphene citrate (brand name Clomid) is a mixture of two isomers: enclomiphene and zuclomiphene, roughly in a 62:38 ratio ^[6]. Enclomiphene is the trans-isomer, thought to be the more potent, faster-clearing antiestrogenic component. Zuclomiphene, the cis-isomer, has a much longer half-life (it can linger in the body for weeks) and is thought to contribute more of clomiphene's estrogenic side effects with less of the beneficial hormone-raising action. The theory behind isolating enclomiphene (this was the basis of the Androxal drug development program by Repros Therapeutics) was that you'd get the LH/FSH-raising benefit without as much zuclomiphene buildup and its associated side effects ^[1]. Clomiphene is FDA-approved, but only for ovulation induction in women; its use in men for testosterone or fertility is off-label. Enclomiphene, by contrast, has never been FDA-approved for any indication. Androxal completed Phase 3 trials but Repros did not get FDA approval, and the drug was never brought to market as a standalone product ^[1]. What's sold today as "enclomiphene" comes from compounding pharmacies, prepared under a prescription for an individual patient rather than as an FDA-approved mass-manufactured drug. That's a meaningfully different regulatory category than a drug like testosterone cypionate or FDA-approved clomiphene, and it's worth understanding before you start.

Why isn't enclomiphene FDA-approved, and does that matter for your first month?

Enclomiphene isn't FDA-approved because its manufacturer, Repros Therapeutics, never won approval despite running the drug (as Androxal) through Phase 3 clinical trials for secondary hypogonadism in men. Repros submitted data to the FDA but did not secure marketing approval, and the company was later acquired, with Androxal never reaching the market ^[1]. What's available now is compounded enclomiphene, made by compounding pharmacies under section 503A or 503B of the Food, Drug, and Cosmetic Act, which allows pharmacies to prepare customized medications for individual patients based on a prescription, without going through the FDA's new drug approval process ^[7]. This is legal, and it's how a lot of legitimate medications reach patients who need a non-standard dose or formulation. But compounded drugs are not FDA-evaluated for safety and efficacy the way approved drugs are, and the FDA's own guidance is direct about this: compounded drugs "are not FDA-approved," and the agency "does not verify the safety or effectiveness of compounded drugs" ^[7]. For your first month, this means a few practical things. Potency and purity depend on the individual compounding pharmacy's quality practices, not on an FDA batch-release standard. There's no FDA-approved package insert with a settled dosing range; dosing (commonly 12.5 mg to 25 mg daily in clinical use) comes from practitioner experience and the leftover trial data, not an approved label. That doesn't mean it's unsafe, plenty of common medications are legally compounded, but it does mean the safety net is different, and it's worth choosing a pharmacy and prescriber who take that seriously. Working with a provider-reviewed source like Enclomiphene Direct means the prescription and dosing plan are physician-reviewed before it goes to a compounding pharmacy, rather than skipping the medical evaluation step entirely.

What should your first-month monitoring plan actually look like?

A reasonable first-month plan includes baseline labs before you start, then a follow-up panel around week 4 to 6. Baseline should cover total and free testosterone, LH, FSH, and estradiol at minimum; some prescribers add a complete blood count and lipid panel, and semen analysis if fertility is an active concern (though as noted above, that's more useful at month 3 than month 1). The follow-up panel at week 4 to 6 is where you actually learn something. If LH and testosterone haven't moved meaningfully by then, that's a signal to reassess dose or reconsider whether enclomiphene is the right fit at all, rather than waiting months hoping it kicks in. Track symptoms alongside labs, not instead of them. A simple weekly note on energy, libido, mood, and sleep quality (1 to 10 scale is fine) gives you and your prescriber something concrete to compare against the numbers. Guessing from memory three months later is unreliable. If you're weighing whether to start at all, is enclomiphene worth it and enclomiphene pros and cons both go through the tradeoffs against TRT and against doing nothing.

How does month one on enclomiphene compare to month one on TRT?

The two approaches diverge almost immediately, and the table below summarizes the practical differences you'd actually notice in the first 4 weeks. | Factor | Enclomiphene (month 1) | Injectable/gel TRT (month 1) |

What does a realistic week-by-week breakdown look like?

Nobody's course is identical, but here's the general pattern reported across clinical trial data and typical prescribing experience. Week 1: Starting dose (commonly 12.5 mg to 25 mg daily). Labs haven't moved much yet. Some men notice nothing; others report mild mood changes or headache as the body adjusts. Week 2: LH is likely rising internally, though you won't see it without labs. Symptom-wise, this is often the trickiest week for side effects if they're going to appear, since hormone shifts are active but not yet stabilized. Week 3: Testosterone often starts climbing meaningfully. Energy and morning erections are the earliest symptom reports for many men. Week 4: First follow-up labs are often scheduled here or in week 5-6. Many men are in or near the normal testosterone range at this point per trial data ^[1][2]. Libido and mood improvements, if they're coming, are often noticeable but not yet fully settled. By the end of month one, expect: better labs, modestly better symptoms, side effects (if any) starting to fade, and a clearer signal on whether to continue at the same dose, adjust, or reconsider the approach entirely. If you want to see real accounts of what men experienced past this point, enclomiphene before and after and enclomiphene success rate cover the longer arc.

Frequently asked questions

How long does it take enclomiphene to raise testosterone?

Most men see testosterone rise into the normal range within 3 to 6 weeks, based on the Androxal Phase 3 trial data and published comparison studies against testosterone gel. Labs are typically checked at week 4 to 6, since that's roughly how long the hypothalamus-pituitary-testes chain takes to reach a new steady state ^[1][2].

Will I feel different in week 1 of enclomiphene?

Probably not much. Hormone levels take a few weeks to shift meaningfully, so week 1 is more about starting the process than feeling results. Some men notice mild mood changes or headache as an early side effect rather than a benefit; genuine symptom improvement (energy, libido) usually shows up starting week 2-3.

Does enclomiphene shrink your testicles like TRT does?

No, and that's the core reason people choose it. Enclomiphene raises LH and FSH, the signals that drive testicular testosterone and sperm production, so testicular size is expected to stay stable or even increase. Exogenous TRT suppresses LH/FSH and is associated with testicular shrinkage over time ^[4].

Is enclomiphene the same as Clomid?

No. Clomid (clomiphene citrate) is a mixture of two isomers, enclomiphene and zuclomiphene, in roughly a 62:38 ratio. Enclomiphene is just the trans-isomer, isolated on the theory that it carries more of the beneficial LH/FSH-raising effect with less of zuclomiphene's long-lasting estrogenic baggage ^[6].

Is enclomiphene FDA-approved?

No. Enclomiphene was developed as Androxal by Repros Therapeutics and completed Phase 3 trials, but never received FDA approval and was never brought to market as an approved drug. What's available today is compounded by pharmacies under a prescription, which is legal but not the same as FDA-approved ^[1][7].

When should I get my first labs after starting enclomiphene?

Most prescribers order follow-up labs at 4 to 6 weeks, checking total and free testosterone, LH, FSH, and estradiol. Testing earlier than that usually just shows a mid-transition snapshot rather than a stable result, since the hormone cascade takes several weeks to settle.

Can enclomiphene affect my mood in the first month?

Yes, mood changes including irritability are among the more commonly reported early effects, likely tied to shifting estradiol and LH as the axis recalibrates. This typically settles within 4 to 6 weeks. Persistent or severe mood changes should be discussed with your prescriber, since a dose adjustment often helps.

Does enclomiphene affect sperm count right away?

No, not that you'd measure in month one. The full spermatogenic cycle takes roughly 64 to 74 days, so even though enclomiphene's mechanism is expected to support sperm production from the start, a semen analysis wouldn't reflect meaningful change until roughly 2 to 3 months of use ^[5].

What's the usual starting dose of enclomiphene?

Clinical use commonly starts around 12.5 mg to 25 mg daily, though this comes from practitioner experience and leftover trial data rather than an FDA-approved label, since enclomiphene never reached approval. Your prescriber will typically adjust based on week 4-6 labs and how you're tolerating it.

Can I switch from TRT to enclomiphene, and what happens in the first month?

Some men do switch, usually to restore fertility or natural function, but it requires letting the suppressed HPT axis restart, which can take longer than a typical enclomiphene-naive start. This should be planned with a prescriber, ideally with baseline labs and realistic timeline expectations rather than assuming an immediate handoff.

What side effects are most common in the first month of enclomiphene?

Mood changes, headache, and occasionally visual disturbances (blurring, floaters) are the most commonly reported effects, based on trial data and clinical use. Visual symptoms warrant stopping and calling your prescriber, since they're a known class effect of SERMs. Most side effects, if they occur, are mild and ease by week 4-6.

Is compounded enclomiphene safe if it's not FDA-approved?

Compounded enclomiphene is legal under FDA rules for pharmacy compounding (503A/503B), but the FDA states it does not verify the safety or effectiveness of compounded drugs the way it does approved medications. Choosing a reputable, provider-reviewed source and compounding pharmacy matters more than it would with an FDA-approved drug ^[7].

Sources

1. ClinicalTrials.gov, Androxal (enclomiphene citrate) Phase 3 study in hypogonadal men: Enclomiphene citrate raised testosterone into the normal range within several weeks in Phase 3 trial data for the discontinued Androxal program
2. Kaminetsky et al., 'A Comparison of the Efficacy of Clomiphene Citrate Enantiomers,' Journal of Sexual Medicine: Enclomiphene raised testosterone while maintaining/increasing LH and FSH, versus testosterone gel which suppressed LH and FSH
3. Kim et al., 'Clomiphene citrate ophthalmic side effects,' PubMed: Visual disturbances are a known class effect associated with clomiphene-related SERM compounds
4. American Urological Association, Guideline on Testosterone Deficiency: Exogenous testosterone therapy suppresses spermatogenesis and is associated with reduced fertility
5. Amann, R.P., 'The cycle of the seminiferous epithelium in humans: a need to revisit?', Journal of Andrology, PMID 18566228: Full sperm maturation (spermatogenesis) takes approximately 64 to 74 days
6. Kerin et al., 'Simultaneous measurement of the isomers of clomiphene in serum,' PubMed: Clomiphene citrate is a mixture of enclomiphene and zuclomiphene isomers in roughly a 62:38 ratio
7. U.S. Food and Drug Administration, 'Human Drug Compounding': FDA states compounded drugs are not FDA-approved and the agency does not verify their safety or effectiveness